Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Revak

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|June 30, 1976
Hageman factor: its structure and modes of activationS D Revak, C G Cochrane
Clinical Immunology and Immunopathology|March 1, 1980
The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulationC G Cochrane, S D Revak
Science (New York, N.Y.)|October 25, 1991
Pulmonary surfactant protein B (SP-B): structure-function relationshipsC G Cochrane, S D Revak
The Journal of Experimental Medicine|September 1, 1980
Dissemination of contact activation in plasma by plasma kallikreinC G Cochrane, S D Revak
The Journal of Clinical Investigation|April 1, 1976
The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the moleculeS D Revak, C G Cochrane
Chest|July 29, 1999
Surfactant lavage treatment in a model of respiratory distress syndromeC G Cochrane, S D Revak
Chest|March 1, 1994
Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis LectureshipC G Cochrane, S D Revak
The Journal of Clinical Investigation|March 1, 1983
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluidC G Cochrane, R Spragg, S D Revak
Federation Proceedings|October 1, 1984
Biochemical factors in pulmonary inflammatory diseaseI Schraufstatter, S D Revak, C G Cochrane
The Journal of Clinical Investigation|April 1, 1984
Proteases and oxidants in experimental pulmonary inflammatory injuryI U Schraufstätter, S D Revak, C G Cochrane
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|June 30, 1976
Hageman factor: its structure and modes of activationS D Revak, C G Cochrane
Clinical Immunology and Immunopathology|March 1, 1980
The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulationC G Cochrane, S D Revak
Science (New York, N.Y.)|October 25, 1991
Pulmonary surfactant protein B (SP-B): structure-function relationshipsC G Cochrane, S D Revak
The Journal of Experimental Medicine|September 1, 1980
Dissemination of contact activation in plasma by plasma kallikreinC G Cochrane, S D Revak
The Journal of Clinical Investigation|April 1, 1976
The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the moleculeS D Revak, C G Cochrane
Chest|July 29, 1999
Surfactant lavage treatment in a model of respiratory distress syndromeC G Cochrane, S D Revak
Chest|March 1, 1994
Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis LectureshipC G Cochrane, S D Revak
The Journal of Clinical Investigation|March 1, 1983
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluidC G Cochrane, R Spragg, S D Revak
Federation Proceedings|October 1, 1984
Biochemical factors in pulmonary inflammatory diseaseI Schraufstatter, S D Revak, C G Cochrane
The Journal of Clinical Investigation|April 1, 1984
Proteases and oxidants in experimental pulmonary inflammatory injuryI U Schraufstätter, S D Revak, C G Cochrane
Pageof 4